Guo, Jingxu http://orcid.org/0000-0002-1568-4842
Liu, Bin
Thorikay, Midory
Yu, Minmin http://orcid.org/0000-0003-4442-7586
Li, Xiaoyan
Tong, Zhen
Salmon, Richard M. http://orcid.org/0000-0001-6327-5341
Read, Randy J. http://orcid.org/0000-0001-8273-0047
ten Dijke, Peter
Morrell, Nicholas W. http://orcid.org/0000-0001-5700-9792
Funding for this research was provided by:
Wellcome Trust (209407/Z/17/Z)
British Heart Foundation (PG/12/54/29734, PG/17/1/32532, FS/SBSRF/20/31005, PG/17/58/33134)
Article History
Received: 20 September 2021
Accepted: 12 April 2022
First Online: 3 May 2022
Competing interests
: W.L. is a founder and scientific advisor to Morphogen-IX. N.W.M. is a founder and CEO of Morphogen-IX. Other authors declare no competing interest.